To amend the Federal Food, Drug, and Cosmetic Act to establish standardized pathogen and microorganism testing of infant formula products and manufacturing facilities, to mandate notification of specific positive tests and inspection classifications, and for other purposes.
HR 7867 mandates standardized pathogen testing of infant formula and facilities with required notification of positive results to strengthen FDA safety oversight.